cilostazol and sildenafil citrate

cilostazol has been researched along with sildenafil citrate in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (18.18)29.6817
2010's7 (63.64)24.3611
2020's2 (18.18)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Clancy, JP; Cobb, BR; Fan, L; Kovacs, TE; Sorscher, EJ1
Beckman, JA; Jaff, MR; Jang, J; Olin, JW; Rooke, T1
Agarwal, N; Ammerman, NC; Bishai, WR; Guo, H; Gupta, R; Lun, S; Maiga, M; Maiga, MC1
Abdul-Majeed, S; Jin, X; Kawanabe, Y; Nauli, AM; Nauli, SM; Sari, Y; Takahashi, M1
Ammerman, NC; Bishai, WR; Maiga, M; Maiga, MC; Murphy, R; Polis, M; Siddiqui, S; Tounkara, A1
Carøe Nordgaard, J; Gammeltoft, S; Kruse, LS; Kruuse, CR1
Bacarin, CC; de Oliveira, JN; de Oliveira, RM; Ferreira, ED; Godinho, J; Milani, H; Zaghi, GG1
Hafez, HM; Mohamed, MZ; Mohammed, HH; Zenhom, NM1
Abdel-Latif, RG; El-Deen, RM; Heeba, GH; Khalifa, MMA1
Abdel-Razek, NS; Salem, HA; Wadie, W1

Reviews

1 review(s) available for cilostazol and sildenafil citrate

ArticleYear
The top 12 advances in vascular medicine.
    Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 2004, Volume: 11 Suppl 2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Cilostazol; Clopidogrel; Factor V; Heparin, Low-Molecular-Weight; Hot Temperature; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metabolic Syndrome; Mutation; Nitric Oxide; Phosphodiesterase Inhibitors; Piperazines; Platelet Aggregation Inhibitors; Purines; Sildenafil Citrate; Sulfones; Tetrazoles; Thrombin; Ticlopidine; Vascular Diseases; Vascular Surgical Procedures

2004

Other Studies

10 other study(ies) available for cilostazol and sildenafil citrate

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Adenosine receptors and phosphodiesterase inhibitors stimulate Cl- secretion in Calu-3 cells.
    American journal of respiratory cell and molecular biology, 2003, Volume: 29, Issue:3 Pt 1

    Topics: Adenosine Deaminase; Anions; Cell Line; Chlorine; Cilostazol; Colforsin; Cyclic AMP; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Electrophysiology; Epithelium; Glyburide; Humans; Hypoglycemic Agents; Milrinone; Mutation; Papaverine; Phosphodiesterase Inhibitors; Piperazines; Purines; Receptors, Purinergic P1; Rolipram; Sildenafil Citrate; Sulfones; Tetrazoles; Time Factors

2003
Successful shortening of tuberculosis treatment using adjuvant host-directed therapy with FDA-approved phosphodiesterase inhibitors in the mouse model.
    PloS one, 2012, Volume: 7, Issue:2

    Topics: Animals; Antitubercular Agents; Cilostazol; Disease Models, Animal; Mice; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tetrazoles; Time Factors; Treatment Outcome; Tuberculosis; United States; United States Food and Drug Administration

2012
Cilostazol prevents endothelin-induced smooth muscle constriction and proliferation.
    PloS one, 2012, Volume: 7, Issue:9

    Topics: Animals; Calcium; Cell Proliferation; Cerebral Arteries; Cilostazol; Cyclic AMP-Dependent Protein Kinases; Cytosol; Dose-Response Relationship, Drug; Endothelins; Flow Cytometry; Immunohistochemistry; Mice; Microscopy, Fluorescence; Muscle, Smooth; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tetrazoles; Vasodilator Agents

2012
Adjuvant host-directed therapy with types 3 and 5 but not type 4 phosphodiesterase inhibitors shortens the duration of tuberculosis treatment.
    The Journal of infectious diseases, 2013, Aug-01, Volume: 208, Issue:3

    Topics: Animals; Antitubercular Agents; Bacterial Load; Cilostazol; Disease Models, Animal; Drug Interactions; Humans; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Phosphodiesterase Inhibitors; Piperazines; Purines; Rifampin; Rolipram; Sildenafil Citrate; Sulfones; Survival Analysis; Tetrazoles; Treatment Outcome; Tuberculosis

2013
Role of Ser102 and Ser104 as regulators of cGMP hydrolysis by PDE5A.
    PloS one, 2014, Volume: 9, Issue:9

    Topics: Amino Acid Substitution; Calcitonin Gene-Related Peptide; Catalytic Domain; Cell Line; Cilostazol; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Humans; In Vitro Techniques; Models, Molecular; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Serine; Sildenafil Citrate; Sulfonamides; Sumatriptan; Tetrazoles

2014
Cilostazol but not sildenafil prevents memory impairment after chronic cerebral hypoperfusion in middle-aged rats.
    Behavioural brain research, 2015, Apr-15, Volume: 283

    Topics: Aging; Amnesia, Retrograde; Animals; Brain Ischemia; Carotid Artery Diseases; Carotid Artery, Internal; Cell Death; Cilostazol; Disease Models, Animal; Male; Maze Learning; Memory, Long-Term; Neuroprotective Agents; Nootropic Agents; Pyramidal Cells; Rats, Wistar; Sildenafil Citrate; Tetrazoles

2015
Cilostazol alleviates streptozotocin-induced testicular injury in rats via PI3K/Akt pathway.
    Life sciences, 2018, Apr-01, Volume: 198

    Topics: Animals; Cilostazol; Diabetes Complications; Diabetes Mellitus, Experimental; Glutathione; Heme Oxygenase (Decyclizing); Hyperglycemia; Infertility, Male; Inflammation; Male; Malondialdehyde; Oxygen; Phosphatidylinositol 3-Kinases; Phosphodiesterase 3 Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Sildenafil Citrate; Streptozocin; Superoxide Dismutase; Testis; Tetrazoles

2018
Comparative effectiveness of phosphodiesterase 3, 4, and 5 inhibitors in amelioration of high-fat diet-induced nonalcoholic fatty liver in rats.
    Fundamental & clinical pharmacology, 2020, Volume: 34, Issue:3

    Topics: Animals; Antioxidants; Biomarkers; Cilostazol; Diet, High-Fat; Fatty Liver; Inflammation; Insulin; Insulin Resistance; Liver; Male; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Pentoxifylline; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Rats; Rats, Wistar; Sildenafil Citrate; Triglycerides

2020
Phosphodiesterase (1, 3 & 5) inhibitors attenuate diclofenac-induced acute kidney toxicity in rats.
    Life sciences, 2021, Jul-15, Volume: 277

    Topics: Acute Kidney Injury; Animals; Blood Urea Nitrogen; Cilostazol; Creatinine; Diclofenac; Kidney; Male; NF-kappa B; Pentoxifylline; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Rats; Rats, Wistar; Sildenafil Citrate; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Vinca Alkaloids

2021